🇺🇸 Fentanyl matrix in United States

304 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Product Quality Issue — 74 reports (24.34%)
  2. Wrong Technique In Product Usage Process — 64 reports (21.05%)
  3. Drug Ineffective — 31 reports (10.2%)
  4. Pain — 29 reports (9.54%)
  5. Overdose — 26 reports (8.55%)
  6. Product Adhesion Issue — 24 reports (7.89%)
  7. Inappropriate Schedule Of Drug Administration — 17 reports (5.59%)
  8. Drug Dose Omission — 13 reports (4.28%)
  9. Drug Use Disorder — 13 reports (4.28%)
  10. Wrong Technique In Drug Usage Process — 13 reports (4.28%)

Source database →

Fentanyl matrix in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Fentanyl matrix approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Fentanyl matrix in United States?

Janssen Korea, Ltd., Korea is the originator. The local marketing authorisation holder may differ — check the official source linked above.